Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Oncogene ; 25(45): 6113-22, 2006 Oct 05.
Artigo em Inglês | MEDLINE | ID: mdl-16652143

RESUMO

A major obstacle for clinicians in the treatment of advanced prostate cancer is the inevitable progression to chemoresistance, especially to docetaxel. It is essential to understand the molecular events that lead to docetaxel resistance in order to identify means to prevent or interfere with chemoresistance. In initial attempts to detect these events, we analysed genomic differences between non-resistant and docetaxel-resistant prostate tumor cells and, of the genes modulated by docetaxel treatment, we observed Stat1 and clusterin gene expression heightened in the resistant phenotype. In this study, we provide biochemical and biological evidence that these two gene products are related. Stat1 and clusterin protein expression was induced upon docetaxel treatment of DU145 cells and highly overexpressed in the docetaxel-resistant DU145 cells (DU145-DR). The increase in total Stat1 corresponded to an increase in phosphorylated Stat1. Interestingly, there was no detectable difference between DU145 and DU145-DR cells expression of total Stat3 and phosphorylated Stat3. Treatment of DU145-DR cells with small interfering RNA targeted for Stat1 not only resulted in the knockdown of Stat1 expression, but it also caused the inhibition of clusterin expression. Thus, Stat1 appears to play a key role in the regulation of clusterin. Remarkably, inhibition of Stat1 or clusterin expression resulted in the re-sensitization of DU145-DR cells to docetaxel. These results offer the first evidence that Stat1, and its subsequent regulation of clusterin, are essential for docetaxel resistance in prostate cancer. Targeting this pathway could be a potential therapeutic means for intervention of docetaxel resistance.


Assuntos
Antineoplásicos Fitogênicos/uso terapêutico , Fator de Transcrição STAT1/fisiologia , Taxoides/uso terapêutico , Sequência de Bases , Linhagem Celular , Clusterina/genética , Primers do DNA , Docetaxel , Resistencia a Medicamentos Antineoplásicos/fisiologia , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Imuno-Histoquímica , Masculino , RNA Interferente Pequeno/fisiologia
2.
South Med J ; 89(4): 365-9, 1996 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-8614873

RESUMO

Angel's trumpet is a hallucinogenic plant commonly cultivated as an ornamental in the southeastern United States. Consumption of any part of the plant may result in severe anticholinergic toxicity. In past years, toxicity has largely resulted from accidental ingestion, but in 1994 there was a ten-fold increase in the number of reported ingestions throughout the state of Florida, largely by persons experimenting with the plant for its hallucinogenic effects. We report three such cases and review the literature on diagnosis, treatment, and sequelae of angel's trumpet intoxication.


Assuntos
Datura stramonium , Alucinógenos , Intoxicação por Plantas , Plantas Medicinais , Plantas Tóxicas , Transtornos Relacionados ao Uso de Substâncias , Adolescente , Adulto , Alucinógenos/intoxicação , Humanos , Masculino , Receptores Muscarínicos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa